Certified by Founder Lodge
Aro Biotherapeutics
United States - Philadelphia, Pennsylvania
START UP
1 Disclosed Funding Rounds $41,500,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Unlocking the Potential of Genetic Medicines
Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a pl
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 29 ,2023 | Series B | $41,500,000 |
Northpond Ventures
HealthCap
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
UPTIQ | $12,000,000 | (Oct 29, 2025)
Flamingo(US) | $2,200,000 | (Oct 29, 2025)
Lula Commerce | $8,000,000 | (Oct 29, 2025)
Cylerity | $4,000,000 | (Oct 29, 2025)
Syllo | $30,000,000 | (Oct 29, 2025)
